NasdaqGM:ATRCMedical Equipment
Assessing AtriCure (ATRC) Valuation After Mixed Share Performance And Clinical Trial Progress
AtriCure (ATRC) has drawn investor attention after a period of mixed share performance, with a loss of 9.18% over the past month but a 16.83% gain in the past 3 months.
See our latest analysis for AtriCure.
At a share price of $36.80, AtriCure’s recent 7 day and 1 month share price returns of 2.57% and 9.18% declines contrast with a 16.83% gain over 90 days. The 1 year, 3 year and 5 year total shareholder returns of 10.96%, 13.92% and 41.49% declines indicate that momentum has only recently...